Antisoma to amend ACCEDE phase III study of AS1413
Hanmi's LAPS-GCSF got the US FDA's approval for clinical trials
YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
Bayer's novel oral contraceptive Qlaira
FDA Approves Additional Use for IUD Mirena to Treat Heavy Menstrual Bleeding in IUD Users
Rockwell Medical Announces Closing of $22 Million Registered Direct Offering of Shares and Warrants
BioInvent updates on the progress of the Phase II trial of the long acting anticoagulant TB-402
CML HealthCare Income Fund Provides Update on U.S. Medical Imaging Acquisition Activity